ARTL: Pangali PEG Artelo
Artelo Biosciences develops endocannabinoid system modulators to combat oncology and neuropathy. Compound synthesis is highly automated via robotics to ensure sterility. The company is currently focusing on publishing clinical trial data for small molecules. The 0.00 metric indicates the status of the ratio between cost and business expansion rates within the price action on the GURU.Markets chart.
Rincian metrik lan analitis perusahaan Artelo Biosciences (ARTL)
- rega saham lan prakiraan rega para ahli:
- informasi kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Artelo Biosciences|ARTL - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal artelobio.com|ARTL - Gunggung utang perusahaan|Utang marang modal buku Artelo|ARTL - Utang jangka dawa perusahaan|Utang jangka cendhak Artelo Biosciences|Likuiditas cepet artelobio.com
- informasi bathi lan kelipatan valuasi:
ARTL - Bathi resik perusahaan|Bathi resik sing dikarepake Artelo Biosciences|ARTL - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi artelobio.com|ARTL - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Artelo|ARTL - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Artelo Biosciences|ARTL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan artelobio.com|ARTL - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Artelo Biosciences
Ringkesan analitik perusahaan:Artelo Biosciences Inc.
Investors utilize this ratio to identify undervalued assets where market value does not align with earnings growth rates. The PEG ratio allows for the filtering of overvalued securities, which is critical for Artelo Biosciences (ARTL), as its valuation depends on clinical success in cancer treatment rather than macroeconomic cycles.
Perusahaan pesaing
INDV: Rasio kapitalisasi marang bathi lan wutah|Pangali PEG COLL (Collegium Pharmaceutical Inc)|Pangali PEG Cronos Corp CRON|CGC - Rasio rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah HITI (hightideinc.com)|auroramj.com (ACB) - Rasio rega marang bathi tumrap wutah|Pangali rega marang bathi tumrap wutah Achieve Life Sciences Inc.|SKYE (Skye Bioscience, Inc.) - Pangali PEG|Pangali PEG Anebulo Pharma|Rasio rega marang bathi tumrap wutah InterCure Ltd. (INCR)|NTRB (nutriband.com) - Koefisien bali modal nimbang wutah|Nasus Pharma - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi IGC (India Globalization Capital)|MIRA Pharma - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah Flora Growth Inc|imcannabis.com (IMCC) - Rasio rega marang bathi tumrap wutah|ADIL (Adial Pharmaceuticals, Inc.) - Rasio rega marang bathi tumrap wutah|Rasio rega marang bathi tumrap wutah Ensysce Biosciences Inc.|Rega marang bathi kanthi panyesuaian wutah Titan Pharma TTNP|Pangali rega marang bathi tumrap wutah GNLN (Greenlane Holdings Inc)|INM (InMed) - Koefisien bali modal nimbang wutah|Pangali PEG AKAN (Akanda)|enveric.com - Rasio rega marang bathi tumrap wutah|Bright Green Corp - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah hempaccoinc.com HPCO
